Michael Malark, PT in North Andover, MA - Physical Therapist

Michael Malark, PT is a Physical Therapist based in North Andover, Massachusetts. Michael Malark is licensed to practice in Massachusetts (license number 17037) and his current practice location is 575 Turnpike St, North Andover, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (978) 686-9688.

NPI number for Michael Malark is 1033310198 and his current mailing address is 43 Wallace Dr, Dover, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1033310198.

Contact Information

	Michael Malark, PT
	575 Turnpike St, North Andover, MA 01845-5924
	(978) 686-9688
	Not Available

Healthcare Provider's Profile

Full Name	Michael Malark
Gender	Male
Speciality	Physical Therapist
Location	575 Turnpike St, North Andover, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1033310198
Provider Enumeration Date: 05/29/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Michael Malark such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033310198	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	17037 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Malark is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Malark, PT 43 Wallace Dr, Dover, NH 03820-5520 Ph: () -	Michael Malark, PT 575 Turnpike St, North Andover, MA 01845-5924 Ph: (978) 686-9688

News Archive

Neovasc commences enrollment in Reducer trial for refractory angina

Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.

IL-10 may improve success rates of skin autografts

Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit burn and accident victims.

Curemark receives FDA clearance for enrollment of children aged 9-12 in CM-AT study for autism

Dr. Joan Fallon, founder and CEO of Curemark, a Rye, New York-based drug research and development company focused on the treatment of Autism and neurological diseases, today announced that the company has received clearance from the Food and Drug Administration (FDA) to commence direct enrollment of children 9-12 years of age into its open-label extension study of CM-AT for children with Autism.

New portable medical devices allow real-time monitoring of therapy efficacy and pathology evolution

Thirteen new PhD students are embarking on a research journey in the area of microwave imaging this month, as part of the EU project EMERALD - ElectroMagnetic imaging for a novel genERation of medicAL Devices.

ViroPharma provides update on recent progress in Cinryze manufacturing expansion activities

ViroPharma is increasing its Cinryze manufacturing capacity through two concurrent efforts. The first project, the parallel chromatography process, was implemented earlier this year and allows production to run across multiple shifts, effectively doubling the capacity of the current manufacturing line and increasing the amount of drug supply available to patients suffering from hereditary angioedema, or HAE.

Physical Therapist in North Andover, MA

Corey Tulley, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 140 Prescott St, North Andover, MA 01845 Phone: 978-685-8086
Susan Marquardt, Physical Therapist Medicare: Medicare Enrolled Practice Location: 336 Boston St, North Andover, MA 01845 Phone: 978-684-2106 Fax: 413-206-7043
Gordon Physical Therapy Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 70 Main St Ste 201, North Andover, MA 01845 Phone: 978-315-2500 Fax: 978-315-2501
Justin Montgomery, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 401 Andover St Ste 102, North Andover, MA 01845 Phone: 978-686-0004
Leah Hughes, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 140 Prescott St, North Andover, MA 01845 Phone: 978-685-8086
Patricia Ghikas, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 186 Bradford St, North Andover, MA 01845 Phone: 978-886-6037

Michael Malark, PT - Physical Therapist in North Andover, MA